Pharmacytimes: Resources: Hepatitis http://www.pharmacytimes.com/condition-resources/hepatitis/condition-rss Hepatitis en-us Sun, 21 Apr 2019 04:48:37 UTC Sun, 21 Apr 2019 04:48:37 UTC Study Examines HCV Retreatment Regimen in Patients with Previous Virologic Failure http://www.pharmacytimes.com/news/ Glecaprevir/pibrentasvir (G/P) plus sofosbuvir and ribavirin can potentially treat patients who experienced previous virologic failure following G/P therapy. AMCP: Industry Shifts to Benefit Complex Patients http://www.pharmacytimes.com/news/ The AMCP Managed Care & Specialty Pharmacy Annual Meeting featured various discussions on strategies to manage complex patients and achieve optimal outcomes, highlighted by an exciting string of innovations and policy shifts. Direct-acting Antivirals Show Real World Efficacy in HCV/HIV Coinfection http://www.pharmacytimes.com/news/ HIV infection is associated with higher rates of hepatitis C replication. How Does Sustained Virologic Response of Hepatitis C Affect Long-Term Health? http://www.pharmacytimes.com/news/ An increasing number of patients with decompensated cirrhosis are receiving direct-acting antiviral treatment and attaining sustained virologic response of hepatitis C, however, their long-term outcomes are unclear. Patients With Cancer Treated for Hepatitis C Still Suitable for Chemo Trials http://www.pharmacytimes.com/news/ Study finds chronic hepatitis C virus infection should not delay the initiation of an urgent cancer therapy. Eradicating HCV, HBV Becoming Realistic Goal http://www.pharmacytimes.com/news/ Achievable steps could be taken to reach the World Health Organization goal of eliminating hepatitis B and C virus infections as public health threats by 2030. Potential Hepatitis C Vaccine Could Help Eradicate Disease http://www.pharmacytimes.com/news/ A novel vaccine to prevent hepatitis C infection has been tested in Baltimore and at two other sites in the United States. Hepatitis C, HIV Drugs Remain Number One in Outpatient Medicaid Spending http://www.pharmacytimes.com/news/ Kaiser Family Foundation analysis examines Medicaid outpatient prescription drug utilization and spending before rebates. Research Suggests Liver Cells are More Susceptible to Cancer http://www.pharmacytimes.com/news/ Study finds that hepatocytes cells respond to inflammation by activating a protein that creates the environment needed for cancer cells to spread. HCV: Direct-Acting Antivirals May Reduce Mortality, Liver Cancer Risk http://www.pharmacytimes.com/news/ The study was the first to compare patients with hepatitis C treated with direct-acting antiviral drugs and those untreated for long-term risks. Study: Highly Cost Effective to Screen Pregnant Women for Hepatitis C http://www.pharmacytimes.com/news/ Because pregnancy is one of the few times individuals are in contact with the health system and covered by health insurance, there is a cost-effective opportunity to screen for hepatitis C virus. Gastric Acid Drugs Not Found to Inhibit Efficacy of Hepatitis C Treatment http://www.pharmacytimes.com/news/ Study finds that glecaprevir/pibrentasvir pan-genotypic efficacy for hepatitis C virus is achieved regardless of whether patients are concurrently receiving gastric acid-reducing drugs. Large Study Supports Direct-Acting Antiviral Link to Reduced Mortality, Liver Cancer Risk in HCV http://www.pharmacytimes.com/news/ New research supports the use of direct-acting antiviral therapy for all individuals with chronic hepatitis C infection. Trending News Today: Supreme Court Rejects Case on Drug Price Gouging Law http://www.pharmacytimes.com/news/ Top news of the day from across the health care landscape. Hepatitis C Antivirals Reduce All-Cause Mortality, Liver Cancer http://www.pharmacytimes.com/news/ Longitudinal study of direct-acting antivirals for hepatitis C virus infection finds that treatment provides clinical benefit beyond virologic response, reducing risk for both all-cause mortality and for liver cancer. Trending News Today: Keytruda Fails to Slow Disease, Extend Survival in Liver Cancer Trial http://www.pharmacytimes.com/news/ Top news of the day across the health care landscape. Trending News Today: Liver Fibrosis Treatment Achieves Main Goal of Late-Stage Study http://www.pharmacytimes.com/news/ Top news of the day across the health care landscape. New Therapy Able to Clear Hepatitis C From Donor Lungs Prior to Transplantation http://www.pharmacytimes.com/news/ A novel method of inactivating hepatitis C virus in donor lungs could increase transplantations for patients with end stage lung disease. Sofosbuvir-Based Regimens Well Tolerated in Asian American Patients with HCV http://www.pharmacytimes.com/news/ Sofosbuvir-based regimens for the treatment of hepatitis C were well tolerated in Asian American communities, according to a new study. Study: Hepatitis B Virus Increases Risk of Age-Related Macular Degeneration http://www.pharmacytimes.com/news/ Those with hepatitis B virus have a significantly elevated risk for developing any type of age-related macular degeneration, according to a new report VSEO N/A